Work

Clinical trial in progress: A phase 3 study of maintenance bi-shRNA-furin/GM-CSF-expressing autologous tumor cell vaccine in women with stage IIIb-IV high-grade epithelial ovarian cancer.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps5604

Authors: Jonathan Oh, Minal A. Barve, Devansu Tewari, John K. Chan, Elizabeth Grosen, Rodney Paul Rocconi, Erin Elizabeth Stevens, Leslie Robbins DeMars, Sharad A. Ghamande, Robert L. Coleman, Luisa Manning, Gladice Wallraven, Neil N. Senzer, Martin Birkhofer, John J. Nemunaitis

Institutions: Texas Oncology, Kaiser Permanente, Palo Alto Medical Foundation, Cancer Care Northwest, University of South Alabama, Billings Clinic, Dartmouth–Hitchcock Medical Center, Augusta University, Augusta University Health, The University of Texas MD Anderson Cancer Center, Gradalis (United States), Mary Crowley Cancer Research Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891908104

Cites:

Cited by: 4

Related to: 10